Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

IBI310 plus sintilimab vs. placebo plus sintilimab in recurrent/metastatic cervical cancer: A double-blind, randomized controlled trial.

Huayi Li | Yu Xu | Xiaofei Jiao | Qin Xu | Zikun Peng | Ying Tang | Jieqing Zhang | Bowen Huang | Yiyang Shen | Baoping Chang | Bairong Xia | Wei Duan | Danbo Wang | Lijing Zhu | Ruifang An | Guonan Zhang | Yaling Tang | Jianli Huang | Hui Qiu | Li Wang | Yi Huang | Guiling Li | Jianhua Qian | Li Sun | Hong Zheng | Ge Lou | Youzhong Zhang | Youguo Chen | Liqin Lu | Yan Cheng | Jihong Liu | Weidong Zhao | Jianghai Ji | Aiqin He | Ke Wang | Guohua Yu | Hong Zhu | Cailing Ma | Jianlin Yuan | Xia Wang | Hongfei Zhang | Xinyan Ma | Chujun Cai | Kang Yin | Han Xie | Ya Wang | Shuyan Wang | Li Li | Hui Zhou | Jing Wang | Jianqing Zhu | Ding Ma | Qinglei Gao
Med (New York, N.Y.) | 2025

It remains unclear whether adding CTLA-4 blockade to PD-1/PD-L1 blockade improves clinical outcomes in cervical cancer (CC).

Pubmed ID: 39827881

Research resources used in this publication

Additional research tools detected in this publication

None found

Antibodies used in this publication

Associated grants

None

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Statistical Analysis System (software resource)

RRID:SCR_008567

Software platform to explore, analyze and visualize data. SAS 9.4 is part of SAS Platform. Standardized data governance and management from statistical software company SAS.

View all literature mentions